Manus Aktteva
We are only a phone call away, Call us on: +91 79 65123395
+91 79 26463395
Home
About Us Pharmaceutical Ingredients, Active Pharmaceutical Rawmaterials, API, Intermediate, Nutraceuticals, Intermediates, Speciality chemicals, Advance level intermediatesEventsNewsEnquiryContact UsResources
Manus Aktteva offers Nilotinib, 641571-10-0, Nilotinib hydrochloride monohydrate, 923288-90-8, for RND and Nilotinib Intermediates for your evaluation, pilots and commercial requirements with supportive technical package required for evaluation.
Products A to Z
       
Search The Site
Please enter all or part of your keyword to retrive data
Search by: Chemical Name
  CAS#
  Molecular Formula
Quick Help
Services
Queries
Tel1: +91 79 65123395
Tel2: +91 79 26463395
Email: click here
Twitter  Facebook
Nilotinib
Nilotinib
Manus Aktteva Biopharma LLP offers Nilotinib, 641571-10-0, Nilotinib hydrochloride monohydrate, 923288-90-8, for RND and Nilotinib Intermediates for your evaluation, pilots and commercial requirements with supportive technical package required for evaluation.
Product Reference ID: MA-GA-551-O
Nilotinib hydrochloride monohydrate
Chemical Name: 4-methyl-N-[3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-benzamide, monohydrochloride, monohydrate
Description
CAS number Nilotinib, 641571-10-0, Nilotinib hydrochloride monohydrate, 923288-90-8
Synonym 4-methyl-N-[3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-benzamide, monohydrochloride, monohydrate, Nilotinib hydrochloride monohydrate
Molecular Formula C28H22F3N7O•HCl • H2O (monohydrate mono-hydrochloride )
Molecular Weight 565.98 (monohydrate mono-hydrochloride )
Specifications Detailed Specifications available on request
Packing As per buyers requirement
Material Safety Data Sheet
Available on request
Availability RND quantities available promptly
Back to Previous Page Click here to Inquire
Are you looking for Nilotinib Intermediates ? Please click here to browse through the list of Nilotinib Intermediates available with us.
Nilotinib, 641571-10-0, Nilotinib hydrochloride monohydrate, 923288-90-8, Nilotinib hcl monohydrate, Nilotinib hydrochloride monohydrate, Nilotinib hydrochlorid monohydrát, Nilotinibhydrochlorid monohydrate, Nilotinib hydrochloride monohydraat, Nilotiniibhüdrokloriid monohüdraat, Nilotinibihydrokloridimonohydraatti, Chlorhydrate de nilotinib monohydraté, Nilotinibhydrochlorid-Monohydrat, Nilotinib-hidroklorid-monohidrát, Nilotinib cloridrato monoidrato, Nilotiniba hidrohlorida monohidrats, Nilotinibo hidrochlorido monohidratas, Nilotynibu chlorowodorek jednowodny, Cloridrato de nilotinib monohidratado, Clorhidrat de nilotinib monohidrat, Monohydrát nilotinibiumchloridu, Nilotinibijev klorid monohidrat, Clorhidrato de nilotinib monohidratado, nilotinibhydrokloridmonohydrat, Nilotinibhydrokloridmonohydrat, Nílótíníb hýdróklóríð einhýdrat
Advertisement
NOTE: 
  • Manus Aktteva Biopharma LLP, India is successfully representing suppliers, manufacturers from INDIA, suppliers, manufacturers from CHINA, and fulfilling the requirements of buyers from EUROPE, USA, South America, Japan, Korea, Taiwan, Australia, & middle-east.
       Keywords: New Molecules, patents, R&D, cas, cas number, product, supplier, suppliers, vendor, vendors, price, prices, api, apis, active pharmaceutical ingredient, ingredients, importer, exporter, distributor, import, export, sale, producer, manufacturer, synthesizer, synthesis, gmp, cgmp, fda, dmf, cgmp, cos, inventory, stock, prompt shipment, compounding, compound, research, development, patent, r and d, pharma
  • Please note that products falling in to controlled substance category shall be exported directly from the manufacturer principals only against receipt of original import permission issued by concerned authorities of the importing country.
PATENTS: 
  • => Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.
        => Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1)
© 2018 MANUS AKTTEVA  All rights reserved..
Payment Procedure